Ronny Allan’s ‘PoNETry’ – An Ode to Lanreotide

Ronny Allan’s ‘PoNETry’ © series can be shared with poetry credit to:

RonnyAllan.NET

Read about my experience with Lanreotide – click here

Thanks for reading

Ronny

I also have PoNETry on Invisible Illness – click here

Click here and answer all questions to join my private Facebook group

• 
  Hey Cancer- it’s been 16 years since my “big surgery”
  D Day  I was 54 years and 9 months old at diagnosis on 26th July 2010.  For the first few months, I had no idea what the outcome would be.  What I did know at the time, given the final staging and grading, in addition to the other damage that was accumulated via various tests,… Read more: Hey Cancer- it’s been 16 years since my “big surgery”
• 
  Don’t miss these 5 posts on RonnyAllan.NET
  Just click on the pictures and read (and hopefully share!)   Disclaimer I am not a doctor or any form of medical professional, practitioner or counsellor. None of the information on my website, or linked to my website(s), or conveyed by me on any social media or presentation, should be interpreted as medical advice given or… Read more: Don’t miss these 5 posts on RonnyAllan.NET
• 
  Ronny Allan’s Newsletter covering October 2026
  Summary of October 2026 on RonnyAllan.NET October was similar to the other months of this year but like July and August, views are down on the previous two months due to 3 weeks of holiday.  Still a reasonable blog performance – I can’t complain.   Still managed to cover 3 new US FDA approvals!  I had… Read more: Ronny Allan’s Newsletter covering October 2026
• 
  I made it to 71!
  I started doing the “Piss off cancer” or “I made it” series when I got to 65, mainly because I initially thought I wouldn’t make that age. I was 54 years and 9 months old at diagnosis on 26th July 2010.  For the first few months, I had no idea what the outcome would be. … Read more: I made it to 71!
• 
  Neuroendocrine Tumours (NET) – Does rising incidence and prevalence need more research, funding and resources?
  The title of this blog is the form of a rhetorical question. Neuroendocrine Tumours (NET) – Does rising incidence and prevalence need more research, funding and resources? I guess if you ask any patient, the answer is a resounding YES.  I also very much guess that many doctors would repeat that answer.  And some are… Read more: Neuroendocrine Tumours (NET) – Does rising incidence and prevalence need more research, funding and resources?
• 
  Ronny Allan’s Newsletter covering September 2026
  Summary of September 2026 on RonnyAllan.NET September was similar to the other months of this year but like July and August, views are down on the previous two months due to 3 weeks of holiday.  Still a reasonable blog performance – I can’t complain.   Still managed to cover 3 new US FDA approvals!  I had… Read more: Ronny Allan’s Newsletter covering September 2026
• 
  Amneal Lanreotide Approved by US FDA
    Amneal launches first CGT‑designated U.S. generic lanreotide — what NET patients need to know Amneal has launched the first Competitive Generic Therapy (CGT)‑designated U.S. generic for lanreotide, a major milestone in a market long dominated by Ipsen’s Somatuline® Depot. The product — lanreotide injection 120 mg/0.5 mL in a sterile single‑dose prefilled syringe —… Read more: Amneal Lanreotide Approved by US FDA
• 
  Ronny Allan’s Newsletter covering August 2026
  Summary of August 2026 on RonnyAllan.NET August was similar to the other months of this year but like July, views are down on the previous two months due to 50% of the month spent on holiday.  Still a reasonable blog performance – I can’t complain.   Other key targets met were three more editions of the Spotlight… Read more: Ronny Allan’s Newsletter covering August 2026
• 
  External Beam Radiation Therapy (EBRT) for Neuroendocrine Neoplasms
  Disclaimer: The information in this section is for education only and does not represent a standard care pathway or service. These treatments are not suitable for everyone, and careful patient selection by an experienced multidisciplinary team is essential. Always discuss your individual situation with your own specialist team.   External Beam Radiation Therapy (EBRT) is… Read more: External Beam Radiation Therapy (EBRT) for Neuroendocrine Neoplasms
• 
  2026 Surveillance Update from Ronny Allan: “See you in 12 months”
  It’s only a couple of weeks since I celebrated my 16th year since diagnosis of metastatic small intestine Neuroendocrine Tumour (NET) at Grade 2 on 26th July 2010.  Thinking back to that period of my life, I’m happy but also slightly amazed to be celebrating such a long milestone having been diagnosed with cancer at… Read more: 2026 Surveillance Update from Ronny Allan: “See you in 12 months”